TY  - GEN
AU  - Manzoni,Paolo
AU  - García Sánchez,Ruben
AU  - Meyer,Michael
AU  - Stolfi,Ilaria
AU  - Pugni,Lorenza
AU  - Messner,Hubert
AU  - Cattani,Silvia
AU  - Betta,Pasqua Maria
AU  - Memo,Luigi
AU  - Decembrino,Lidia
AU  - Bollani,Lina
AU  - Rinaldi,Matteo
AU  - Fioretti,Maria
AU  - Quercia,Michele
AU  - Maule,Milena
AU  - Tavella,Elena
AU  - Mussa,Alessandro
AU  - Tzialla,Chryssoula
AU  - Laforgia,Nicola
AU  - Mosca,Fabio
AU  - Magaldi,Rosario
AU  - Mostert,Michael
AU  - Farina,Daniele
TI  - Exposure to Gastric Acid Inhibitors Increases the Risk of Infection in Preterm Very Low Birth Weight Infants but Concomitant Administration of Lactoferrin Counteracts This Effect
SN  - 1097-6833
PY  - 2019///0219
KW  - Administration, Oral
KW  - Dietary Supplements
KW  - Enterocolitis, Necrotizing
KW  - epidemiology
KW  - Gastric Acid
KW  - Histamine H2 Antagonists
KW  - adverse effects
KW  - Humans
KW  - Infant, Newborn
KW  - Infant, Premature
KW  - Infant, Very Low Birth Weight
KW  - Intensive Care Units, Neonatal
KW  - Italy
KW  - Lacticaseibacillus rhamnosus
KW  - Lactoferrin
KW  - administration & dosage
KW  - New Zealand
KW  - Probiotics
KW  - Proton Pump Inhibitors
KW  - Risk Factors
KW  - Sepsis
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.jpeds.2017.09.080
ER  -